Physician profile

Robert Sorabella

Cardiovascular Disease · Birmingham, AL

NPI 1376867093

$16,331.05

in general payments reported to CMS, 2019-2025

13 companies · $957 in 2025

The $957 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$10,937.50
Food and Beverage$2,575.27
Travel and Lodging$2,270.72

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Edwards Lifesciences Corporation $12,749.27 2024 Edwards Sapien 3 Transcatheter Heart Valve (Thv), The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System
Artivion, INC. $1,664.19 2020-2025 Cardiac Non-Synergraft, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Cryovalve Sg Pulmonary Human Heart Valve
Baxter Healthcare $397.14 2022-2025 Perclot
Paragonix Technologies, INC. $234.73 2025 Lungguard, Baroguard, Sherpapak
Bolton Medical INC $220.38 2019
Abbott Laboratories $207.28 2023-2024 Epic, Navitor
Zimmer Biomet Holdings, INC. $172.49 2024-2025 Sternalock 360 System, A&E Medical / Sternalock Xp Rigid Fixation System, Medline
Atricure, INC. $167.88 2024-2025 Atricure Cryoice Cryoablation System (Cryo2)
Medtronic, INC. $165.00 2022
Surgical Specialties Corporation (US), INC. (Dba Corza Medical) $151.45 2025
Abiomed $146.40 2025
Lemaitre Vascular, INC. $38.11 2024-2025 Restoreflow
Ethicon US, LLC $16.73 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Robert Sorabella

$16,331.05

in general payments reported 2019-2025

Years
2019-2025
Top company
Edwards Lifesciences Corporation
Context
The $957 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/1400817/robert-sorabella

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.